12th November 2020

  • Funding Pressure Could Return Via Year-End GSIB Scores: JPMorgan

https://blinks.bloomberg.com/news/stories/QJLTRCT1UM1E

  • Funding Pressure Unlikely to Re-Emerge From GSIB Scores: Pozsar

https://blinks.bloomberg.com/news/stories/QJNT2ZDWX2PV

  • This Covid Surge Is America’s Longest — and It’s Getting Longer

https://blinks.bloomberg.com/news/stories/QJN3VADWX2Q0

  • Moderna Poised to Take Vaccine Spotlight With Data Due

Initial verdict could come in days as national cases ramp up

Effectiveness expected to be similar to Pfizer’s 90% rate
https://blinks.bloomberg.com/news/stories/QJNL3CDWLU6L

CLICK HERE TO READ THE FULL ARTICLE

For more information please contact Rubrics Asset Management. info@rubricsam.com.